Deadline: 11-Jun-2026
The R Accelerated Award Grant provides up to $800,000 over four years to support innovative pediatric oncology research. It targets early-career investigators with original, high-impact projects aimed at developing safer and more effective treatments for childhood cancers. This grant prioritizes projects with strong scientific rationale and clear, testable hypotheses that accelerate therapeutic discovery.
What is the R Accelerated Award Grant?
The R Accelerated Award Grant is a specialized funding opportunity for pediatric oncology research. Its goal is to advance treatments for childhood cancers by supporting projects that:
- Are original and not currently funded
- Address a clearly defined, testable scientific hypothesis
- Focus on accelerating therapeutic discovery for pediatric cancers
- Aim to improve efficacy while reducing toxicity
This grant is designed for early-career researchers to drive innovative solutions in childhood cancer treatment.
Funding Details
- Total Funding: Up to $800,000 USD over four years
- Annual Funding: Maximum of $200,000 per year
- Eligible Costs: Direct research costs (supplies, small equipment, travel, fringe benefits)
- Ineligible Costs: Indirect costs, tuition remission
- Salary Cap: Must comply with NIH salary limits
Who is Eligible?
Applicants must meet the following criteria:
- Affiliation: Nonprofit organizations in the United States or Canada
- Education: MD, PhD, MD/PhD, DO, MBBS, or equivalent
- Career Stage: Within ten years of the first faculty appointment at Assistant Professor level (higher ranks allowed)
- Research Status: Not lead PIs on active ALSF-funded grants, serving as PI or co-PI/MPI on first NIH R01 or equivalent award (awarded Jan 2021 or later) focused on pediatric cancer, only one such award per applicant is permitted
Applicants do not need to hold U.S. citizenship.
Why This Grant Matters
- Childhood cancers require safer, more effective therapies
- Early-career investigators often face funding barriers; this grant enables high-risk, high-reward research
- Accelerates translation of lab discoveries into therapeutic options
How to Apply
- Prepare Your Proposal: Clearly define your research question and hypothesis, outline methodology and expected outcomes, include budget and justification within allowed limits
- Confirm Eligibility: Verify your institution qualifies, ensure you meet career stage and prior award criteria
- Submit Application: Follow the official grant submission portal instructions, include all required documents and certifications
- Review & Selection: Applications are evaluated based on scientific merit, innovation, and potential impact on pediatric oncology
Common Mistakes to Avoid
- Requesting indirect costs or tuition remission
- Applying while serving as lead PI on active ALSF-funded grants
- Submitting proposals without a clearly defined, testable hypothesis
- Overlooking NIH salary cap compliance
FAQ
1. Can international researchers apply? Yes, applicants do not need U.S. citizenship, but the institution must be a nonprofit in the U.S. or Canada.
2. Can senior faculty apply? Yes, higher academic ranks are permitted, but the applicant should be within ten years of their first faculty appointment for early-career consideration.
3. Are indirect costs allowed? No, the grant only covers direct costs.
4. Can the grant fund tuition or education costs? No, tuition remission is not allowed.
5. Can I apply if I hold multiple NIH R01 awards? No, only applicants with their first R01 or equivalent award focused on pediatric cancer within the last five years are eligible.
6. What projects are prioritized? Projects that are innovative, high-impact, and aimed at accelerating therapies for pediatric cancer.
7. How is funding distributed? Up to $200,000 per year over four years, for a total maximum of $800,000.
Conclusion
The R Accelerated Award Grant is a pivotal funding opportunity for early-career researchers in pediatric oncology. It enables innovative projects that aim to improve the safety and effectiveness of childhood cancer treatments. By targeting high-impact research with clear hypotheses, this grant accelerates the path from discovery to therapy.
For more information, visit ALSF.
